Purple Biotech Ltd.

NASDAQ: PPBT · Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT

Purple Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
5.77M 7.4M 5.44M 6.52M 9.98M 14.49M 15.1M 17.2M 21.88M 15.03M 11.07M 14.01M 23.54M 10.89M 9.12M 10.54M 10.2M
Short-Term Investments
1.31M 1.12M 862K 867K 869K 923K 980K 1.2M 1.24M 17.08M 22.01M 22.01M 16.01M 36.31M 36.45M 37.85M 45.26M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 187K 187K 187K 187K n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.64M 2.64M 2.66M 160K 5.02M 5.02M 3.07M
Receivables
n/a 275K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 500K 500K 500K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.00 n/a n/a
Other Current Assets
428K 109K 638K 473K 548K 171K 634K 984K 1.29M 146K 1.22M 1.43M 2.35M 268K 1.13M 1.11M 1.49M
Total Current Assets
7.51M 8.91M 6.94M 7.86M 11.4M 15.79M 16.72M 19.38M 24.41M 33.26M 34.31M 37.45M 41.9M 48.47M 47.2M 50M 57.44M
Property-Plant & Equipment
237K 288K 325K 359K 417K 470K 510K 571K 628K 682K 725K 780K 867K 896K 931K 991K 959K
Goodwill & Intangibles
27.84M 27.84M 27.84M 27.84M 28.04M 28.04M 28.04M 28.04M 28.04M 20.68M 20.68M 20.68M 20.68M 20.48M 20.48M 20.48M 20.48M
Total Long-Term Assets
28.08M 28.13M 28.17M 28.2M 28.46M 28.51M 28.55M 28.61M 28.67M 21.37M 24.24M 24.29M 24.39M 21.73M 26.43M 26.49M 24.51M
Total Assets
35.59M 37.04M 35.1M 36.06M 39.86M 44.3M 45.27M 48M 53.08M 54.62M 58.54M 61.74M 66.29M 70.2M 73.63M 76.49M 81.95M
Account Payables
868K 1.46M 1.91M 3.04M 3.48M 3.53M 2.59M 1.57M 2.45M 2.13M 2.77M 1.23M 1.65M 1.47M 2.08M 2.07M 1.33M
Deferred Revenue
n/a n/a n/a 2.15M 2.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
411K 1.15M 1.56M 1.1M 2.05M 673K 3.45M 3.12M 2.98M 698K 2.98M 3.97M 5.34M 611K 1.14M n/a n/a
Total Current Liabilities
2.76M 3.99M 5.46M 6.47M 8.51M 7.18M 6.22M 4.88M 5.62M 7.06M 5.93M 5.39M 7.19M 4.25M 3.43M 3.5M 5.97M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
140K 140K 141K 141K 141K 2.66M 141K 141K 141K 145K 143K 292K 292K 292K 265K 265K 265K
Total Long-Term Liabilities
140K 140K 179K 220K 262K 2.82M 333K 378K 419K 466K 500K 691K 787K 842K 828K 870K 887K
Total Liabilities
2.9M 4.13M 5.64M 6.69M 8.77M 10.01M 6.55M 5.25M 6.04M 7.52M 6.43M 6.08M 7.97M 5.09M 4.25M 4.37M 6.86M
Total Debt
137K 183K 222K 261K 307K 351K 370K 421K 467K 515K 550K 594K 694K 749K 762K 804K 829K
Common Stock
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Retained Earnings
-145.15M -144.69M -144.28M -143.62M -141.22M -137.45M -132.63M -127.59M -122.45M -117.58M -111.56M -106.74M -103.2M -95.91M -90.83M -87.7M -84.07M
Comprehensive Income
-98K -98K -98K 37.34M -98K 10.01M 10.18M 9.93M 10.6M 10.06M 9.69M 9.18M 8.89M 8.76M 9.67M 9.27M 8.73M
Shareholders Equity
32.65M 32.86M 29.41M 29.32M 31.02M 34.21M 38.6M 42.6M 46.88M 46.91M 51.89M 55.41M 58.06M 64.83M 69.06M 71.8M 74.75M
Total Investments
1.31M 1.12M 862K 867K 869K 923K 980K 1.2M 1.24M 17.08M 22.2M 22.2M 16.2M 36.5M 36.45M 37.85M 45.26M